ArticleInternational journal of clinical practice2021
Pleural effusion as an indicator for the poor prognosis of COVID-19 patients.
Article in International journal of clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.Journal of medical virology · 2022Pooled it
- HALP score and 30-day mortality: an observational analysis of clinical associations in Pneumonia.PeerJ · 2026Observational
- Analyzing pleural fluid attributes in SARS-CoV-2 infection: a systematic review.Journal of thoracic disease · 2025Review
- Outcomes of Tube Thoracostomies in COVID-19 Patients: A Retrospective Cohort Study in the University of the Philippines - Philippine General Hospital COVID-19 Referral Center.Acta medica Philippina · 2024Article
- A Possible Association Between COVID-19 Vaccine and Complicated Pleural Effusion: A Case Report.Cureus · 2023Article
- Unilateral Pleural Effusion after Third Dose of BNT162b2 mRNA Vaccination: Case Report.Journal of personalized medicine · 2023Article
- Pleural Effusion in COVID-19 Pneumonia: Clinical and Prognostic Implications-An Observational, Retrospective Study.Journal of clinical medicine · 2023Article
- Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers.Diagnostics (Basel, Switzerland) · 2022Article
- Chest CT as a Prognostic Tool in COVID-19.Archivos de bronconeumologia · 2022Article
- Can Lung Ultrasound Be the Ideal Monitoring Tool to Predict the Clinical Outcome of Mechanically Ventilated COVID-19 Patients? An Observational Study.Healthcare (Basel, Switzerland) · 2022Article
- Time to hospitalisation, CT pulmonary involvement and in-hospital death in COVID-19 patients in an Emergency Medicine Unit.International journal of clinical practice · 2021Observational
- Pleural effusion as an indicator for the poor prognosis of COVID-19 patients.International journal of clinical practice · 2021Article
- Chest CT performance and features of COVID-19 in the region of Abu Dhabi, UAE: a single institute study.Chinese journal of academic radiology · 2021Article
- Homogeneous ensemble models for predicting infection levels and mortality of COVID-19 patients: Evidence from China.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCoronavirus Disease 19 (COVID-19) is a global health concern that has become a pandemic over the past few months. This study aims at understanding the clinical manifestations of COVID-19 patients with pleural effusion.
methodsCOVID-19 patients were retrospectively enrolled from the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Pharyngeal swabs from patients were tested using real-time polymerase chain reaction. Patients with COVID-19 were divided into two groups based on their computed tomography (CT) scans for the presence of pleural effusion at admission. We compared the clinical features, laboratory findings, scans and clinical outcomes between the two groups.
resultsPleural effusion was observed in 9.19% of the patients. Patients with pleural effusion were more likely to be severe or critical cases. Moreover, patients with pleural effusion were associated with increased mortality. Of the 799 discharged patients, patients with pleural effusion had longer hospital stays and duration of viral shedding since the onset of symptoms as compared with that for patients without pleural effusion. After discharge, 217 patients visited for a follow-up CT re-examination at the Union Hospital. The CT scans showed that patients with pleural effusion required a longer time to resolve the lung inflammation after the onset of COVID-19 as compared with the time required by patients without pleural effusion.
conclusionThis population of patients requires special attention and pleural effusion may be an indicator of poor prognosis in COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.